The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 10/2019, Volume 144, Issue 4, pp. 931 - 932
Mast cells play a central role in asthma pathophysiology, and both the location and density of mast cells in asthmatic patients are seemingly important for...
Hyperresponsiveness | exercise | asthma | mannitol | bronchoconstriction | ALLERGY | IMMUNOLOGY | Laboratories | Smooth muscle | Inflammation | Muscle contraction | Asthma | Chymase | Studies | Respiratory tract | Histamine | Bronchoconstriction | Mannitol | Mast cells | In vitro methods and tests | Drug dosages
Hyperresponsiveness | exercise | asthma | mannitol | bronchoconstriction | ALLERGY | IMMUNOLOGY | Laboratories | Smooth muscle | Inflammation | Muscle contraction | Asthma | Chymase | Studies | Respiratory tract | Histamine | Bronchoconstriction | Mannitol | Mast cells | In vitro methods and tests | Drug dosages
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 137, Issue 2, pp. 444 - 451.e8
Background The SQ HDM SLIT-tablet (ALK) has been developed for treatment of house dust mite (HDM)–induced respiratory allergic disease. Objective This trial...
Allergy and Immunology | rhinoconjunctivitis | total combined rhinitis score | sublingual immunotherapy tablet | allergen immunotherapy | house dust mite | Allergy immunotherapy | Rhinitis Quality of Life Questionnaire | allergy | sublingual immunotherapy | allergic rhinitis | STANDARDIZATION | EFFICACY | SAFETY | IMMUNOLOGY | CHILDREN | IMMUNOTHERAPY TABLET | CLINICAL-TRIALS | ASTHMA | NORTH-AMERICAN | RESPIRATORY ALLERGY | Rhinitis, Allergic - immunology | Humans | Middle Aged | Risk Factors | Sublingual Immunotherapy - methods | Male | Treatment Outcome | Young Adult | Allergens - administration & dosage | Antigens, Dermatophagoides - immunology | Animals | Allergens - immunology | Time Factors | Adolescent | Adult | Female | Aged | Rhinitis, Allergic - therapy | Pyroglyphidae - immunology | Clinical trials | Product development | Clinics | Consulting services | Allergens | Care and treatment | Rhinitis | Analysis | Immunotherapy | Conjunctivitis | Population | Drug therapy | Allergies | Asthma | Life Sciences | Allergology | Immunology
Allergy and Immunology | rhinoconjunctivitis | total combined rhinitis score | sublingual immunotherapy tablet | allergen immunotherapy | house dust mite | Allergy immunotherapy | Rhinitis Quality of Life Questionnaire | allergy | sublingual immunotherapy | allergic rhinitis | STANDARDIZATION | EFFICACY | SAFETY | IMMUNOLOGY | CHILDREN | IMMUNOTHERAPY TABLET | CLINICAL-TRIALS | ASTHMA | NORTH-AMERICAN | RESPIRATORY ALLERGY | Rhinitis, Allergic - immunology | Humans | Middle Aged | Risk Factors | Sublingual Immunotherapy - methods | Male | Treatment Outcome | Young Adult | Allergens - administration & dosage | Antigens, Dermatophagoides - immunology | Animals | Allergens - immunology | Time Factors | Adolescent | Adult | Female | Aged | Rhinitis, Allergic - therapy | Pyroglyphidae - immunology | Clinical trials | Product development | Clinics | Consulting services | Allergens | Care and treatment | Rhinitis | Analysis | Immunotherapy | Conjunctivitis | Population | Drug therapy | Allergies | Asthma | Life Sciences | Allergology | Immunology
Journal Article
Expert Review of Clinical Immunology, ISSN 1744-666X, 11/2019, Volume 15, Issue 11, pp. 1127 - 1133
Introduction: Allergic rhinitis (AR) is one of the most common chronic conditions affecting both children and adults. The house dust mites (HDM) account for a...
asthma | house dust mite | Allergic rhinoconjunctivitis | sublingual | immunotherapy
asthma | house dust mite | Allergic rhinoconjunctivitis | sublingual | immunotherapy
Journal Article
JAMA, ISSN 0098-7484, 04/2016, Volume 315, Issue 16, pp. 1715 - 1725
IMPORTANCE: The house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet is a potential novel treatment option for HDM allergy–related asthma....
Immunotherapy - methods | Administration, Sublingual | Asthma - prevention & control | Tablets | Humans | Immunoglobulin G | Middle Aged | Male | Rhinitis - drug therapy | Young Adult | Allergens - administration & dosage | Antigens, Dermatophagoides - administration & dosage | Asthma - immunology | Adrenergic beta-2 Receptor Agonists - therapeutic use | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Rhinitis - immunology | Double-Blind Method | Administration, Inhalation | Treatment Outcome | Asthma - drug therapy | Disease Progression | Dust | Animals | Adolescent | Quality of Life | Albuterol - therapeutic use | Aged | Adrenal Cortex Hormones - administration & dosage | Pyroglyphidae - immunology | Usage | Care and treatment | House-dust mite | Corticosteroids | Immunotherapy | Dosage and administration | Health aspects | Risk factors | Asthma | Side effects | Drug use | Allergies
Immunotherapy - methods | Administration, Sublingual | Asthma - prevention & control | Tablets | Humans | Immunoglobulin G | Middle Aged | Male | Rhinitis - drug therapy | Young Adult | Allergens - administration & dosage | Antigens, Dermatophagoides - administration & dosage | Asthma - immunology | Adrenergic beta-2 Receptor Agonists - therapeutic use | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Rhinitis - immunology | Double-Blind Method | Administration, Inhalation | Treatment Outcome | Asthma - drug therapy | Disease Progression | Dust | Animals | Adolescent | Quality of Life | Albuterol - therapeutic use | Aged | Adrenal Cortex Hormones - administration & dosage | Pyroglyphidae - immunology | Usage | Care and treatment | House-dust mite | Corticosteroids | Immunotherapy | Dosage and administration | Health aspects | Risk factors | Asthma | Side effects | Drug use | Allergies
Journal Article
5.
Full Text
Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD
Respiratory Medicine, ISSN 0954-6111, 2013, Volume 107, Issue 10, pp. 1481 - 1490
Summary Suboptimal adherence to pharmacological treatment of asthma and chronic obstructive pulmonary disease (COPD) has adverse effects on disease control and...
Pulmonary/Respiratory | Respiratory disease | Therapy regimens | Healthcare resources | Clinical outcomes | Quality of life | MILD ASTHMA | CARDIAC & CARDIOVASCULAR SYSTEMS | REPEATED INSTRUCTION | PERSISTENT ASTHMA | OBSTRUCTIVE PULMONARY-DISEASE | PEDIATRIC ASTHMA | RESPIRATORY SYSTEM | FLUTICASONE PROPIONATE/SALMETEROL COMBINATION | CORTICOSTEROID USE | INNER-CITY CHILDREN | MEDICATION ADHERENCE | ORAL MONTELUKAST | Medication Adherence | Health Care Costs - statistics & numerical data | Humans | Respiratory System Agents - administration & dosage | Respiratory System Agents - therapeutic use | Administration, Inhalation | Treatment Outcome | Asthma - drug therapy | Pulmonary Disease, Chronic Obstructive - economics | Asthma - economics | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - drug therapy | Patient outcomes | Health care reform | Medical care | Respiratory agents | Patient compliance | Cost control | Asthma | Quality management | Medical care, Cost of | Studies | Chronic obstructive pulmonary disease | Patient satisfaction | Drug therapy | Mortality | Hälsovetenskap | Lungmedicin och allergi | Klinisk medicin | Medicin och hälsovetenskap | Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi
Pulmonary/Respiratory | Respiratory disease | Therapy regimens | Healthcare resources | Clinical outcomes | Quality of life | MILD ASTHMA | CARDIAC & CARDIOVASCULAR SYSTEMS | REPEATED INSTRUCTION | PERSISTENT ASTHMA | OBSTRUCTIVE PULMONARY-DISEASE | PEDIATRIC ASTHMA | RESPIRATORY SYSTEM | FLUTICASONE PROPIONATE/SALMETEROL COMBINATION | CORTICOSTEROID USE | INNER-CITY CHILDREN | MEDICATION ADHERENCE | ORAL MONTELUKAST | Medication Adherence | Health Care Costs - statistics & numerical data | Humans | Respiratory System Agents - administration & dosage | Respiratory System Agents - therapeutic use | Administration, Inhalation | Treatment Outcome | Asthma - drug therapy | Pulmonary Disease, Chronic Obstructive - economics | Asthma - economics | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - drug therapy | Patient outcomes | Health care reform | Medical care | Respiratory agents | Patient compliance | Cost control | Asthma | Quality management | Medical care, Cost of | Studies | Chronic obstructive pulmonary disease | Patient satisfaction | Drug therapy | Mortality | Hälsovetenskap | Lungmedicin och allergi | Klinisk medicin | Medicin och hälsovetenskap | Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2009, Volume 104, Issue 2, pp. 166 - 171
Summary Background Poor adherence to asthma treatment is a well-recognised challenge and is associated with increased morbidity, mortality and consumption of...
Pulmonary/Respiratory | Adherence | Follow-up study | Treatment | Compliance | Telemedicine | Asthma | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | RESPIRATORY SYSTEM | ADULTS | CHILDREN | Medication Adherence - statistics & numerical data | Medication Adherence - psychology | Follow-Up Studies | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Asthma - psychology | Male | Treatment Outcome | Asthma - drug therapy | Young Adult | Reminder Systems | Adolescent | Adult | Female | Cell Phone | Respiratory Function Tests | Respiratory agents | Patient compliance | Studies | Medicine | Patient education | Cellular telephones | Nitric oxide | Drug dosages | Chronic illnesses
Pulmonary/Respiratory | Adherence | Follow-up study | Treatment | Compliance | Telemedicine | Asthma | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | RESPIRATORY SYSTEM | ADULTS | CHILDREN | Medication Adherence - statistics & numerical data | Medication Adherence - psychology | Follow-Up Studies | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Asthma - psychology | Male | Treatment Outcome | Asthma - drug therapy | Young Adult | Reminder Systems | Adolescent | Adult | Female | Cell Phone | Respiratory Function Tests | Respiratory agents | Patient compliance | Studies | Medicine | Patient education | Cellular telephones | Nitric oxide | Drug dosages | Chronic illnesses
Journal Article
BMC Public Health, ISSN 1471-2458, 2010, Volume 10, Issue 1, pp. 524 - 524
Background: Chronic Obstructive Pulmonary Disease (COPD) is among the leading causes of death in the world, and further increases in the prevalence and...
POPULATION | DIAGNOSIS | OBSTRUCTIVE PULMONARY-DISEASE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HIGH-RISK | SMOKERS | GENERAL-PRACTICE | SPIROMETRY | ASTHMA | PRIMARY-HEALTH-CARE | Pulmonary Disease, Chronic Obstructive - diagnosis | Humans | Mass Screening - standards | Denmark - epidemiology | Surveys and Questionnaires | Primary Health Care | Program Evaluation | Respiratory Function Tests | National Health Programs | Early Diagnosis | Pulmonary Disease, Chronic Obstructive - epidemiology | Lung diseases, Obstructive | Care and treatment | Diagnosis | Research | Risk factors | Hospitals | Health services | Mortality | Questionnaires | Committees | Family physicians
POPULATION | DIAGNOSIS | OBSTRUCTIVE PULMONARY-DISEASE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HIGH-RISK | SMOKERS | GENERAL-PRACTICE | SPIROMETRY | ASTHMA | PRIMARY-HEALTH-CARE | Pulmonary Disease, Chronic Obstructive - diagnosis | Humans | Mass Screening - standards | Denmark - epidemiology | Surveys and Questionnaires | Primary Health Care | Program Evaluation | Respiratory Function Tests | National Health Programs | Early Diagnosis | Pulmonary Disease, Chronic Obstructive - epidemiology | Lung diseases, Obstructive | Care and treatment | Diagnosis | Research | Risk factors | Hospitals | Health services | Mortality | Questionnaires | Committees | Family physicians
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 140, Issue 2, pp. 407 - 417.e11
Background Asthmatic patients have higher microbiome diversity and an altered composition, with more Proteobacteria and less Bacteroidetes compared with...
Allergy and Immunology | noneosinophilic asthma | asthma | Airway inflammation | bacteria | microbiome | bronchoalveolar lavage | ACTIVATION | HIGH-THROUGHPUT | MAST-CELLS | PATHOLOGY | MANNITOL | IMMUNOLOGY | OBSTRUCTIVE PULMONARY-DISEASE | ALLERGY | Eosinophilia - metabolism | Sputum - cytology | Asthma - metabolism | Eosinophilia - microbiology | Humans | Male | Eosinophils - immunology | Mannitol - pharmacology | Bronchoalveolar Lavage Fluid - microbiology | Forced Expiratory Volume | Young Adult | Microbiota | Asthma - immunology | Adult | DNA, Bacterial - analysis | Female | Leukocyte Count | Eosinophilia - physiopathology | Asthma - microbiology | Asthma - physiopathology | Neutrophils - immunology | Bacteria - genetics | Bacteria - isolation & purification | Eosinophilia - immunology | Nitric Oxide - metabolism | Inflammation | Asthma | Bacteria | Nitric oxide | Analysis | rRNA 16S | Image processing | Control methods | Diagnostic tests | Infections | Gene sequencing | Respiratory tract | Microorganisms | Bronchoalveolar lavage | Mannitol | Respiratory tract diseases | Alveoli | Deoxyribonucleic acid--DNA | Leukocytes (eosinophilic) | Lung diseases | Neutrophils | Bronchus | Abundance | Leukocytes (neutrophilic) | Gene expression | Patients | Eosinophilia | Image analysis | Biopsy | Sputum | Neutrophilia | DNA sequencing | Eosinophils | Indexing
Allergy and Immunology | noneosinophilic asthma | asthma | Airway inflammation | bacteria | microbiome | bronchoalveolar lavage | ACTIVATION | HIGH-THROUGHPUT | MAST-CELLS | PATHOLOGY | MANNITOL | IMMUNOLOGY | OBSTRUCTIVE PULMONARY-DISEASE | ALLERGY | Eosinophilia - metabolism | Sputum - cytology | Asthma - metabolism | Eosinophilia - microbiology | Humans | Male | Eosinophils - immunology | Mannitol - pharmacology | Bronchoalveolar Lavage Fluid - microbiology | Forced Expiratory Volume | Young Adult | Microbiota | Asthma - immunology | Adult | DNA, Bacterial - analysis | Female | Leukocyte Count | Eosinophilia - physiopathology | Asthma - microbiology | Asthma - physiopathology | Neutrophils - immunology | Bacteria - genetics | Bacteria - isolation & purification | Eosinophilia - immunology | Nitric Oxide - metabolism | Inflammation | Asthma | Bacteria | Nitric oxide | Analysis | rRNA 16S | Image processing | Control methods | Diagnostic tests | Infections | Gene sequencing | Respiratory tract | Microorganisms | Bronchoalveolar lavage | Mannitol | Respiratory tract diseases | Alveoli | Deoxyribonucleic acid--DNA | Leukocytes (eosinophilic) | Lung diseases | Neutrophils | Bronchus | Abundance | Leukocytes (neutrophilic) | Gene expression | Patients | Eosinophilia | Image analysis | Biopsy | Sputum | Neutrophilia | DNA sequencing | Eosinophils | Indexing
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2016, Volume 194, Issue 9, pp. 1062 - 1072
The larynx is one of the most highly innervated organs in humans and serves a number of vitally important, complex, and highly evolved biological functions. On...
Wheeze | Larynx | Vocal | Dyspnea | Cough | wheeze | vocal | TOXIN TYPE-A | dyspnea | VOCAL-CORD DYSFUNCTION | REFLEX SENSITIVITY | cough | BOTULINUM TOXIN | larynx | INHALED SODIUM CROMOGLYCATE | RESPIRATORY SYSTEM | INDUCED BRONCHOCONSTRICTION | EXERTIONAL DYSPNEA | PLACEBO-CONTROLLED TRIAL | FOLD MOVEMENT | REFRACTORY CHRONIC COUGH | CRITICAL CARE MEDICINE | Laryngeal Diseases - therapy | Laryngeal Diseases - diagnosis | Humans | Larynx - physiopathology | Laryngeal Diseases - physiopathology | Laryngeal Diseases - epidemiology | Laryngoscopy
Wheeze | Larynx | Vocal | Dyspnea | Cough | wheeze | vocal | TOXIN TYPE-A | dyspnea | VOCAL-CORD DYSFUNCTION | REFLEX SENSITIVITY | cough | BOTULINUM TOXIN | larynx | INHALED SODIUM CROMOGLYCATE | RESPIRATORY SYSTEM | INDUCED BRONCHOCONSTRICTION | EXERTIONAL DYSPNEA | PLACEBO-CONTROLLED TRIAL | FOLD MOVEMENT | REFRACTORY CHRONIC COUGH | CRITICAL CARE MEDICINE | Laryngeal Diseases - therapy | Laryngeal Diseases - diagnosis | Humans | Larynx - physiopathology | Laryngeal Diseases - physiopathology | Laryngeal Diseases - epidemiology | Laryngoscopy
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2008, Volume 122, Issue 2, pp. 254 - 260.e7
Respiratory symptoms cannot be relied on to make a diagnosis of asthma and/or airways hyperresponsiveness (AHR) in elite athletes. For this reason, the...
Allergy and Immunology | airway hyperresponsiveness | environment | Respiratory symptoms | bronchial provocation | endurance training | asthma | exercise-induced bronchoconstriction | Olympic Games | β 2-agonists | agonists | BRONCHIAL HYPERRESPONSIVENESS | RESPIRATORY HEALTH SURVEY | AIRWAY INFLAMMATION | INHALED CORTICOSTEROIDS | IMMUNOLOGY | CROSS-COUNTRY SKIERS | INDUCED BRONCHOSPASM | respiratory symptoms | beta-agonists | ALLERGY | EUCAPNIC VOLUNTARY HYPERVENTILATION | FINE PARTICULATE MATTER | ICE HOCKEY PLAYERS | Asthma, Exercise-Induced - etiology | Bronchoconstriction - physiology | Asthma, Exercise-Induced - diagnosis | Humans | Bronchial Provocation Tests | Adrenergic beta-Agonists - therapeutic use | Asthma, Exercise-Induced - prevention & control | Adrenergic beta-Agonists - adverse effects | Asthma, Exercise-Induced - therapy | Sports | Olympic athletes | Respiratory agents | Conferences, meetings and seminars | Sports associations | Asthma | Ventilation | Physical fitness | Athletes | Gene expression | Olympic games
Allergy and Immunology | airway hyperresponsiveness | environment | Respiratory symptoms | bronchial provocation | endurance training | asthma | exercise-induced bronchoconstriction | Olympic Games | β 2-agonists | agonists | BRONCHIAL HYPERRESPONSIVENESS | RESPIRATORY HEALTH SURVEY | AIRWAY INFLAMMATION | INHALED CORTICOSTEROIDS | IMMUNOLOGY | CROSS-COUNTRY SKIERS | INDUCED BRONCHOSPASM | respiratory symptoms | beta-agonists | ALLERGY | EUCAPNIC VOLUNTARY HYPERVENTILATION | FINE PARTICULATE MATTER | ICE HOCKEY PLAYERS | Asthma, Exercise-Induced - etiology | Bronchoconstriction - physiology | Asthma, Exercise-Induced - diagnosis | Humans | Bronchial Provocation Tests | Adrenergic beta-Agonists - therapeutic use | Asthma, Exercise-Induced - prevention & control | Adrenergic beta-Agonists - adverse effects | Asthma, Exercise-Induced - therapy | Sports | Olympic athletes | Respiratory agents | Conferences, meetings and seminars | Sports associations | Asthma | Ventilation | Physical fitness | Athletes | Gene expression | Olympic games
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 126, Issue 5, pp. 952 - 958
Background Studies of selected patient groups have shown that airway hyperresponsiveness (AHR) to mannitol is more specific than methacholine for the diagnosis...
Allergy and Immunology | airway hyperresponsiveness | epidemiology | inflammation | exhaled nitric oxide | diagnosis | mannitol | methacholine | Asthma | population | Methacholine | Exhaled nitric oxide | Mannitol | Population | Inflammation | Diagnosis | Epidemiology | Airway hyperresponsiveness | TESTS | RESPONSIVENESS | INHALED CORTICOSTEROIDS | SENSITIVITY | MARKERS | ASTHMATIC SUBJECTS | IMMUNOLOGY | CHALLENGE | ALLERGY | ADOLESCENTS | ATOPIC ASTHMA | Asthma - diagnosis | Bronchial Hyperreactivity - chemically induced | Bronchial Provocation Tests - methods | Cross-Sectional Studies | Area Under Curve | Humans | Male | Nitric Oxide - analysis | Young Adult | Sensitivity and Specificity | Adolescent | Female | ROC Curve | Bronchoconstrictor Agents | Exhalation | Nitric Oxide - metabolism | Methacholine Chloride | Respiratory agents | Nitric oxide | Studies
Allergy and Immunology | airway hyperresponsiveness | epidemiology | inflammation | exhaled nitric oxide | diagnosis | mannitol | methacholine | Asthma | population | Methacholine | Exhaled nitric oxide | Mannitol | Population | Inflammation | Diagnosis | Epidemiology | Airway hyperresponsiveness | TESTS | RESPONSIVENESS | INHALED CORTICOSTEROIDS | SENSITIVITY | MARKERS | ASTHMATIC SUBJECTS | IMMUNOLOGY | CHALLENGE | ALLERGY | ADOLESCENTS | ATOPIC ASTHMA | Asthma - diagnosis | Bronchial Hyperreactivity - chemically induced | Bronchial Provocation Tests - methods | Cross-Sectional Studies | Area Under Curve | Humans | Male | Nitric Oxide - analysis | Young Adult | Sensitivity and Specificity | Adolescent | Female | ROC Curve | Bronchoconstrictor Agents | Exhalation | Nitric Oxide - metabolism | Methacholine Chloride | Respiratory agents | Nitric oxide | Studies
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2017, Volume 140, Issue 3, pp. 710 - 719
Background The Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study profiled patients with mild, moderate, and severe asthma and nonatopic...
Allergy and Immunology | phenotypes | type 2 inflammation | airway mucosal gene expression | biomarkers | Asthma | CYTOKINES | MEPOLIZUMAB | EOSINOPHILS | VALIDATION | MONOCLONAL-ANTIBODY | IMMUNOLOGY | PERIOSTIN | EPITHELIAL-CELLS | ALLERGY | EXHALED NITRIC-OXIDE | EXPRESSION | EOTAXIN | Asthma - metabolism | Chemokines, CC - blood | Humans | Middle Aged | Interleukin-13 - immunology | Male | Cell Adhesion Molecules - immunology | Chemokine CCL26 | Eosinophils - immunology | Young Adult | Interleukin-13 - genetics | Asthma - blood | Respiratory Mucosa - immunology | Asthma - immunology | Chemokine CCL17 - immunology | Adult | Female | Chemokines, CC - immunology | Leukocyte Count | Chemokine CCL17 - blood | Biomarkers - metabolism | Severity of Illness Index | Cell Line | Gene Expression | Asthma - physiopathology | Biomarkers - blood | Adolescent | Respiratory Function Tests | Nitric Oxide - metabolism | Medical research | Genes | Immunoglobulin E | Inflammation | Gene expression | Cells | Homeopathy | Materia medica and therapeutics | Nitric oxide | Therapeutics | Medicine, Experimental | Biological markers | Cytokines | Leukocytes (eosinophilic) | Mucosa | Smooth muscle | Population studies | Interleukin 13 | Kinases | Patients | Respiratory tract | Biopsy | Cell lines | Biomarkers | Bioindicators | CCL17 protein | Chemokines
Allergy and Immunology | phenotypes | type 2 inflammation | airway mucosal gene expression | biomarkers | Asthma | CYTOKINES | MEPOLIZUMAB | EOSINOPHILS | VALIDATION | MONOCLONAL-ANTIBODY | IMMUNOLOGY | PERIOSTIN | EPITHELIAL-CELLS | ALLERGY | EXHALED NITRIC-OXIDE | EXPRESSION | EOTAXIN | Asthma - metabolism | Chemokines, CC - blood | Humans | Middle Aged | Interleukin-13 - immunology | Male | Cell Adhesion Molecules - immunology | Chemokine CCL26 | Eosinophils - immunology | Young Adult | Interleukin-13 - genetics | Asthma - blood | Respiratory Mucosa - immunology | Asthma - immunology | Chemokine CCL17 - immunology | Adult | Female | Chemokines, CC - immunology | Leukocyte Count | Chemokine CCL17 - blood | Biomarkers - metabolism | Severity of Illness Index | Cell Line | Gene Expression | Asthma - physiopathology | Biomarkers - blood | Adolescent | Respiratory Function Tests | Nitric Oxide - metabolism | Medical research | Genes | Immunoglobulin E | Inflammation | Gene expression | Cells | Homeopathy | Materia medica and therapeutics | Nitric oxide | Therapeutics | Medicine, Experimental | Biological markers | Cytokines | Leukocytes (eosinophilic) | Mucosa | Smooth muscle | Population studies | Interleukin 13 | Kinases | Patients | Respiratory tract | Biopsy | Cell lines | Biomarkers | Bioindicators | CCL17 protein | Chemokines
Journal Article
Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 2014, Volume 2, Issue 6, pp. 759 - 767.e2
Background The prevalence of severe asthma is unknown. However, international expert statements estimate that severe asthma represents 5% to 10 % of the entire...
Internal Medicine | Allergy and Immunology | asthma | Prescription data | Severe asthma | Asthma control | Asthma management | Asthma | MORTALITY | SPECIALIST CARE | MANAGEMENT | INHALED CORTICOSTEROIDS | VALIDATION | GENERAL-PRACTICE | IMMUNOLOGY | ORGANIZATION | ALLERGY | EXACERBATIONS | QUALITY-OF-LIFE | OUTCOMES | Health Resources - utilization | Ambulatory Care - utilization | Prevalence | Age Factors | Anti-Asthmatic Agents - therapeutic use | Humans | Male | Drug Utilization Review | Young Adult | Adult | Female | Registries | Emergency Service, Hospital - utilization | Referral and Consultation - utilization | Asthma - epidemiology | Asthma - diagnosis | Severity of Illness Index | Asthma - physiopathology | Cross-Sectional Studies | Treatment Outcome | Hospitalization | Lung - physiopathology | Asthma - drug therapy | Drug Prescriptions | Lung - drug effects | Adolescent | Denmark - epidemiology | Health Care Surveys | Studies | Prescription drugs | Classification | Population | Chronic obstructive pulmonary disease | Personal identification numbers | Drug dosages | Patients
Internal Medicine | Allergy and Immunology | asthma | Prescription data | Severe asthma | Asthma control | Asthma management | Asthma | MORTALITY | SPECIALIST CARE | MANAGEMENT | INHALED CORTICOSTEROIDS | VALIDATION | GENERAL-PRACTICE | IMMUNOLOGY | ORGANIZATION | ALLERGY | EXACERBATIONS | QUALITY-OF-LIFE | OUTCOMES | Health Resources - utilization | Ambulatory Care - utilization | Prevalence | Age Factors | Anti-Asthmatic Agents - therapeutic use | Humans | Male | Drug Utilization Review | Young Adult | Adult | Female | Registries | Emergency Service, Hospital - utilization | Referral and Consultation - utilization | Asthma - epidemiology | Asthma - diagnosis | Severity of Illness Index | Asthma - physiopathology | Cross-Sectional Studies | Treatment Outcome | Hospitalization | Lung - physiopathology | Asthma - drug therapy | Drug Prescriptions | Lung - drug effects | Adolescent | Denmark - epidemiology | Health Care Surveys | Studies | Prescription drugs | Classification | Population | Chronic obstructive pulmonary disease | Personal identification numbers | Drug dosages | Patients
Journal Article